Advertisement
Screener

ORASURE TECHNOLOGIES, INC (OSUR) Debt Components

ORASURE TECHNOLOGIES, INC (OSUR) Debt Components

  • 2019-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Line of CreditUSD $0.00; Line of Credit Facility, Unused Capacity, Commitment Fee Percentagepure (m); Line of Credit Facility, Maximum Borrowing CapacityUSD (m).
  • 2018-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Line of CreditUSD $0.00; Line of Credit Facility, Unused Capacity, Commitment Fee Percentagepure (m); Line of Credit Facility, Maximum Borrowing CapacityUSD (m).
  • 2018-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Line of Credit Facility, Unused Capacity, Commitment Fee Percentagepure 12 month · 0.38%; Line of Credit Facility, Maximum Borrowing CapacityUSD (m).
  • 2018-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Line of Credit Facility, Unused Capacity, Commitment Fee Percentagepure (m); Line of Credit Facility, Maximum Borrowing CapacityUSD $10.00M.

ORASURE TECHNOLOGIES, INC Debt Components

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endLong-term Debt, Current Maturities
USD
Long-term Line of Credit
USD
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage
pure
Line of Credit Facility, Maximum Borrowing Capacity
USD
Line of Credit Facility, Remaining Borrowing Capacity
USD
Line of Credit Facility, Interest Rate During Period
pure
Line of Credit Facility, Periodic Payment, Principal
USD
Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
USD
2019-12-31(m)$0.00(m)(m)(m)(m)(m)(m)
2018-12-31(m)$0.00(m)(m)(m)(m)(m)(m)
2018-12-31(m)(m)12 month · 0.38%(m)(m)(m)(m)(m)
2018-12-31(m)(m)(m)$10.00M(m)(m)(m)(m)
2018-09-30(m)(m)9 month · 0.38%(m)(m)(m)(m)(m)
2018-09-30(m)$0.00(m)$10.00M(m)(m)(m)(m)
2018-06-30(m)(m)6 month · 0.38%(m)(m)(m)(m)(m)
2018-06-30(m)$0.00(m)$10.00M(m)(m)(m)(m)
2018-03-31(m)(m)3 month · 0.38%(m)(m)(m)(m)(m)
2018-03-31(m)$0.00(m)$10.00M(m)(m)(m)(m)
2017-12-31(m)$0.00(m)(m)(m)(m)(m)(m)
2017-12-31(m)(m)12 month · 0.38%(m)(m)(m)(m)(m)
2017-12-31(m)(m)(m)$10.00M(m)(m)(m)(m)
2017-09-30(m)(m)9 month · 0.38%(m)(m)(m)(m)(m)
2017-09-30(m)$0.00(m)$10.00M(m)(m)(m)(m)
2017-06-30(m)(m)6 month · 0.38%(m)(m)(m)(m)(m)
2017-06-30(m)$0.00(m)$10.00M(m)(m)(m)(m)
2017-03-31(m)(m)3 month · 0.38%(m)(m)(m)(m)(m)
2017-03-31(m)$0.00(m)$10.00M(m)(m)(m)(m)
2016-12-31(m)$0.00(m)(m)(m)(m)(m)(m)
2016-12-31(m)(m)12 month · 0.38%(m)(m)(m)(m)(m)
2016-12-31(m)(m)(m)$10.00M(m)(m)(m)(m)
2016-09-30(m)(m)9 month · 0.38%(m)(m)(m)(m)(m)
2016-09-30(m)$0.00(m)$10.00M(m)(m)(m)(m)
2012-12-31(m)(m)(m)(m)(m)12 month · 4.15%(m)(m)
2012-09-30(m)(m)(m)(m)(m)(m)9 month · $7.04M(m)
2012-07-31(m)(m)(m)(m)(m)(m)1 month · $7.04M(m)
2012-07-30(m)(m)(m)(m)(m)(m)1 month · $7.04M(m)
2012-07-30(m)(m)(m)(m)$0.00(m)(m)(m)
2012-07-30(m)(m)(m)(m)(m)(m)(m)$10.00M
2012-06-30(m)(m)(m)(m)(m)6 month · 4.15%(m)(m)
2012-06-30$7.04M(m)(m)$10.00M$0.00(m)(m)(m)
2012-03-31$7.17M(m)(m)(m)(m)(m)(m)(m)
2011-12-31(m)(m)(m)$10.00M(m)(m)(m)(m)
2011-12-31$7.29M(m)(m)(m)(m)(m)(m)(m)
2011-09-30$7.42M(m)(m)(m)(m)(m)(m)(m)
2011-06-30$7.54M(m)(m)(m)(m)(m)(m)(m)
2010-12-31$7.79M(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25